Enveric Biosciences, Inc. (ENVB)
Data as of , from SEC Form 4 filings.
See up to 3 months of ENVB. The 7-day demo opens the 1M and 3M ranges and puts ENVB on your watchlist.
Start 7-day demoLatest ENVB insider trades
About Enveric Biosciences, Inc. (ENVB)
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
- CAMBRIDGE, MA
- 6
- 1995
- Nasdaq
ENVB Form 4 activity by transaction type, last 90 days
No Form 4 activity for ENVB in the last 90 days.
ENVB insider transactions (Form 4)
2323 Form 4 filings on record, the earliest from Oct 11, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kevin Michael Coveney - Officer | Grant or award | Common Stock | 133,333 footnote F1 | $0.00 | - | |
| ||||||
| Joseph Edward Tucker - Officer | Grant or award | Common Stock | 201,124 footnote F1 | $0.00 | - | |
| ||||||
| Frank Pasqualone | Grant or award | Common Stock | 18,518 footnote F1 | $0.00 | - | |
| ||||||
| Michael D. Webb | Grant or award | Common Stock | 18,518 footnote F1 | $0.00 | - | |
| ||||||
| Marcus Schabacker | Grant or award | Common Stock | 18,518 footnote F1 | $0.00 | - | |
| ||||||
| George A. Kegler | Grant or award | Common Stock | 18,518 footnote F1 | $0.00 | - | |
| ||||||
| Sheila Dewitt | Grant or award | Common Stock | 18,518 footnote F1 | $0.00 | - | |
| ||||||
| Peter J. Facchini - Officer | Grant or award | Common Stock | 25,000 footnote F1 | $0.00 | - | |
| ||||||
| Sheila Dewitt | Grant or award | Common Stock | 7,633 footnote F1 | $0.00 | - | |
| ||||||
| George A. Kegler | Grant or award | Common Stock | 7,633 footnote F1 | $0.00 | - | |
| ||||||
| Frank Pasqualone | Grant or award | Common Stock | 7,633 footnote F1 | $0.00 | - | |
| ||||||
| Marcus Schabacker | Grant or award | Common Stock | 7,633 footnote F1 | $0.00 | - | |
| ||||||
| Joseph Edward Tucker - Officer | Grant or award | Common Stock | 60,296 footnote F1 | $0.00 | - | |
| ||||||
| Michael D. Webb | Grant or award | Common Stock | 7,633 footnote F1 | $0.00 | - | |
| ||||||
| Kevin Michael Coveney - Officer | Grant or award | Common Stock | 40,198 footnote F1 | $0.00 | - | |
| ||||||
| Sheila Dewitt | Grant or award | Common Stock | 27,845 | $0.00 | - | |
| Kevin Michael Coveney - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - | |
| Peter J. Facchini - Officer | Grant or award | Common Stock | 40,000 | $0.00 | - | |
| Joseph Edward Tucker - Officer | Grant or award | Common Stock | 161,633 | $0.00 | - | |
| George A. Kegler | Grant or award | Common Stock | 47,733 | $0.00 | - | |
| Marcus Schabacker | Grant or award | Common Stock | 47,733 | $0.00 | - | |
| Frank Pasqualone | Grant or award | Common Stock | 47,733 | $0.00 | - | |
| Michael D. Webb | Grant or award | Common Stock | 47,733 | $0.00 | - | |
Item 2.02, 9.01
Item 8.01, 9.01
Item 7.01, 9.01
Item 5.02, 5.07, 9.01
ENVB insider trading FAQ
What is the latest insider trade for ENVB?
Enveric Biosciences, Inc. (ENVB) has filed no insider reports in the last 90 days. The most recent on record is dated 3 June 2026. The full record for ENVB runs to 23 Form 4 filings, the earliest from 11 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ENVB stock?
No insider purchases of ENVB were filed in the last 90 days.
How many insiders are selling ENVB stock?
No insider sales of ENVB were filed in the last 90 days.
Where can I see ENVB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ENVB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kevin Michael Coveney view on EDGAR
- - Joseph Edward Tucker view on EDGAR
- - Frank Pasqualone view on EDGAR
- - Michael D. Webb view on EDGAR
- - Marcus Schabacker view on EDGAR
- - George A. Kegler view on EDGAR
- - Sheila Dewitt view on EDGAR
- - Peter J. Facchini view on EDGAR
- - Sheila Dewitt view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ENVB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ENVB with a 7-day demo
- ENVB on your watchlist
- Every ENVB Form 4 filing on record
- Up to 3 months of ENVB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
